An innovative Australian study has trialled a new mental health intervention designed specifically for people with aphasia, a communication disability most commonly caused by stroke. The program, called Aphasia PRevention, Intervention and Support in Mental health (Aphasia PRISM), aims to...
In a world-first initiative, the recruitment for the Protect Me trial targeting fetal growth restriction (FGR), a condition in which an unborn baby is smaller than expected, has now been completed. This trial, which began...
Am I doing this right? Am I producing enough milk for my baby? Are they still hungry? These are just a few of the questions swirling in a first-time mother’s head, on top of trying...
We invite you to delve into the latest edition of Monash Health’s Research Matters newsletter to read about all the latest research and innovation being undertaken across our health service. This quarterly publication is your ticket to...
We’d like to take a moment to recognise the incredible work and dedication of our clinical researchers. Their tireless efforts are advancing human health study by study, patient by patient, in communities here and around...
Monash Health is excited to announce the seven recipients of the 2025 Emerging Researcher Fellowships. The coveted program invests in early-career research individuals with significant potential by supporting them to conduct a translational research project. ...
Most experts and those experiencing the potentially debilitating features of Polycystic Ovary Syndrome (PCOS), which affects one in eight women, want greater awareness and a name change to improve care and outcomes. A new research paper reveals...
Monash Health research has uncovered the power of caregiver concern in predicting serious illness in patients. It is now one of the vital signs that will be monitored at Monash Health hospitals. ...
A groundbreaking international study has revealed that a new drug, luspatercept, significantly outperforms the current standard treatment for anaemia in patients with lower-risk myelodysplastic syndromes (MDS). The COMMANDS trial analysed the difference between the drugs luspatercept and epoetin...
Dr Eliza Szwarcberg, a medical intern at Monash Children’s Hospital, is making an impact with her research on the use of intravesical Botox injections in children with functional urinary incontinence. Dr Szwarcberg's research focuses on over...